Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
58 participants
INTERVENTIONAL
2026-02-28
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: Parents will report increased vaccine confidence scores post-intervention.
Data from this study will provide preliminary data for a larger scale evaluation of the intervention.
Participants will be asked to complete surveys, view a web-based intervention and then visit with their child's healthcare provider.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Evaluation of Tailored Messages to Address Parental Questions About HPV Vaccination
NCT03628885
PREVENT Pilot HPV - Related Cancers Trial
NCT06738355
Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness
NCT05006833
Usability of HPV Vaccine Reminders
NCT03987490
Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV
NCT06959563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Parents' Stories Web Application + Provider Elaborated Prompts
Participating parents will be asked to navigate a web application that consists of (a) brief, 90-second narrative videos that encourage parent-provider communication about the vaccine and (b) personalized feedback to parents that is tailored to provide educational content in response to their concerns and be motivational in nature. Providers will provide elaborated prompts related to the vaccine when meeting with parents tailored to their concerns.
Web Application
A web application for vaccine-hesitant parents and their teens with brief, 90-second narrative videos and tailored, motivational content
Provider Elaborated Prompts
A component for providers that suggests elaborated prompts to be used with parents that align with the content of the web application, are tailored to parent concerns, and are motivational in nature
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Web Application
A web application for vaccine-hesitant parents and their teens with brief, 90-second narrative videos and tailored, motivational content
Provider Elaborated Prompts
A component for providers that suggests elaborated prompts to be used with parents that align with the content of the web application, are tailored to parent concerns, and are motivational in nature
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* status as a U.S. resident
* self-reported ability to read English
* self-reported HPV vaccine hesitant using established methodology
Exclusion Criteria
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Anne E Ray
OTHER
Real Prevention, LLC
INDUSTRY
Merck Institute for Therapeutic Research
UNKNOWN
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne E Ray
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne E Ray, PhD.
Role: PRINCIPAL_INVESTIGATOR
University of Kentucky
Aaron Kruse-Diehr, PhD
Role: STUDY_CHAIR
University of Kentucky
Michael Hecht, PhD
Role: STUDY_CHAIR
Real Prevention, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kentucky
Lexington, Kentucky, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
95632
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.